John Brendan Doyle - 29 Jul 2025 Form 4 Insider Report for COGNITION THERAPEUTICS INC (CGTX)

Role
Chief Financial Officer
Signature
/s/ John Brendan Doyle
Issuer symbol
CGTX
Transactions as of
29 Jul 2025
Net transactions value
-$6,273
Form type
4
Filing time
31 Jul 2025, 16:23:52 UTC
Previous filing
02 May 2025
Next filing
22 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Doyle John Brendan Chief Financial Officer C/O COGNITION THERAPEUTICS, INC., 2500 WESTCHESTER AVE, PURCHASE /s/ John Brendan Doyle 31 Jul 2025 0001840738

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CGTX Common Stock Award $0 +30,000 +7.4% $0.000000 434,710 29 Jul 2025 Direct F1
transaction CGTX Common Stock Tax liability $6,273 -9,360 -2.2% $0.6702 425,350 29 Jul 2025 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares earned upon the vesting of performance stock units ("PSUs") granted to the Reporting Person on February 14, 2024. Each PSU represents a contingent right to receive one share of the Issuer's Common Stock upon the achievement of certain performance goals. 50% of the total number of shares subject to the PSUs vested on July 29, 2025.
F2 Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of PSUs.